Therapeutic Modalities for SARS-CoV-2 (COVID-19): Current Status and Role of Protease Inhibitors to Block Viral Entry Into Host Cells

Therapeutic Modalities for SARS-CoV-2 (COVID-19): Current Status and Role of Protease Inhibitors to Block Viral Entry Into Host Cells

An acute respiratory disease (SARS-CoV-2, also recognized as COVID-19/2019-nCoV), caused by nCoV created a worldwide emergency. The World Health Organization declared the SARS-CoV-2 as epidemic of international concern on January 2020. After SARS-CoV in 2002 and MERS-CoV in 2012, the emergence of SA...

Full description

Bibliographic Details
Main Authors: Sarmad Ahmad Qamar, Kanta Basharat, Muhammad Bilal, Hafiz M.N. Iqbal
Format: Article
Language:English
Published: Journal of Pure and Applied Microbiology 2020-09-01
Series:Journal of Pure and Applied Microbiology
Subjects:
sars-cov-2
covid-19
origin
therapeutics
protease inhibitors
gene silencing (sirna)
interferons type i (ifn-1)
Online Access:https://microbiologyjournal.org/therapeutic-modalities-for-sars-cov-2-covid-19-current-status-and-role-of-protease-inhibitors-to-block-viral-entry-into-host-cells/

Internet

https://microbiologyjournal.org/therapeutic-modalities-for-sars-cov-2-covid-19-current-status-and-role-of-protease-inhibitors-to-block-viral-entry-into-host-cells/

Similar Items